VIVATRONIX and SpineX announce xStep device approval from CDSCO
VIVATRONIX Tech and SpineX have announced approval from India’s Central Drugs Standard Control Organisation (CDSCO) for the xStep device to…
Neurology Devices
-
-
Clearmind signs distribution agreement with Sutter Medical for Neuroblade system
Clearmind Biomedical has teamed up with Sutter Medical Technologies USA for the exclusive distribution of its Neuroblade multi-function neuro-endoscope system…
-
Elutia to divest bioenvelopes business to Boston Scientific for $88m
Elutia has reached a definitive agreement to sell its EluPro and CanGaroo bioenvelopes to Boston Scientific for $88m in cash.…
-
AAIC25: Cognito neuromodulation therapy slows decline in Alzheimer’s disease
Cognito Therapeutics has presented new data demonstrating its Spectris neuromodulation device’s potential to slow cognitive decline and preserve white matter…
-
FDA approves Felix NeuroAI Wristband for essential tremor treatment
Fasikl has received 510(k) clearance from the US Food and Drug Administration (FDA) for its Felix NeuroAI Wristband, designed to…
-
MicroTransponder highlights promising long-term data for VNS system
US-based MicroTransponder has reported positive long-term results for stroke patients who received the company’s paired vagus nerve stimulation (VNS) therapy.…
-
Neuralink wins FDA breakthrough tag for speech restoration
The US Food and Drug Administration (FDA) has awarded Neuralink’s brain-computer interface breakthrough device designation for the treatment of individuals…
-
FDA grants expanded 510(k) clearance for Epitel’s wireless EEG system
The US Food and Drug Administration (FDA) has granted expanded 510(k) clearance for Epitel’s REMI Wireless electroencephalogram (EEG) System for…
-
Helius joins BCI landscape with new subsidiary
Helius Medical Technologies is muscling in on the promising brain computer interface (BCI) field with the launch of a new…
-
Vivani Medical to spin-off neurostim business Cortigent as public company
Vivani Medical will spin off Cortigent, its neurostimulation business, as an independently publicly traded company as it looks to prioritise…
